Idogen AB Interim report January-March 2018
Interim report, 1 January-31 March 2018 FIRST QUARTER (JANUARY-MARCH 2018) · Other operating income amounted to KSEK 0 (0) · Operating loss totalled KSEK -7,108 (-3,275) · Loss for the period totalled KSEK -6,841 (-3,277) · Cash flow from operating activities was KSEK 4,794 (-2,733) · Loss per share before dilution was SEK -0.33 (-0.27). Loss per share after dilution was SEK -0.18 (-0.27). SIGNIFICANT EVENTS IN THE FIRST QUARTER · In January, the EU paid the first portion of the Horizon 2020 research funding, an amount of MEUR 1.2. Additional funding of MEUR 1.